Ceapro Inc. (CVE:CZO – Get Free Report) shares fell 11.8% during trading on Friday . The stock traded as low as C$0.23 and last traded at C$0.23. 5,850 shares were traded during mid-day trading, a decline of 88% from the average session volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Stock Performance
The company’s fifty day moving average price is C$0.22 and its two-hundred day moving average price is C$0.23. The company has a debt-to-equity ratio of 8.07, a quick ratio of 18.88 and a current ratio of 8.54. The firm has a market capitalization of C$688,880.00, a PE ratio of -2.83 and a beta of 1.38.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Read More
- Five stocks we like better than Ceapro
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
- Rocket Lab’s Stock Drop Comes With a Bullish Twist
- Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
